| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Brief Report on the Patterns of Mediastinal Nodal Failure in Resectable Stage IB-IIIA NSCLC Treated With Neoadjuvant Immunotherapy Combinations, a Secondary Analysis of a Prospective Trial
|
Mao, Serena
|
|
|
25 |
1 |
p. e67-e71
|
artikel
|
| 2 |
Adherence to Annual Lung Cancer Screening in a Centralized Academic Program
|
Lee, Grace
|
|
|
25 |
1 |
p. e18-e25
|
artikel
|
| 3 |
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
|
Zhang, Jia-Tao
|
|
|
25 |
1 |
p. e1-e4
|
artikel
|
| 4 |
A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small-Cell Lung Cancer: TORG2241 (UBE-Q)
|
Nakamichi, Shinji
|
|
|
25 |
1 |
p. 85-90
|
artikel
|
| 5 |
Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non–Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data
|
Adachi, Hiroyuki
|
|
|
25 |
1 |
p. 61-71.e1
|
artikel
|
| 6 |
Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC
|
Lu, Kevin
|
|
|
25 |
1 |
p. e58-e61
|
artikel
|
| 7 |
Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation
|
Hayasaka, Kazuki
|
|
|
25 |
1 |
p. e43-e51
|
artikel
|
| 8 |
CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhibitor Resistance in Patient With EGFR-Mutated NSCLC With CNS Progression
|
Jurica, James M.
|
|
|
25 |
1 |
p. 77-79
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
25 |
1 |
p. A1
|
artikel
|
| 10 |
Effect of Sequence of Radiotherapy Combined With Immunotherapy on the Incidence of Pneumonitis in Patients With Lung Cancer: A Systematic Review and Network Meta-Analysis
|
Mi, Song
|
|
|
25 |
1 |
p. 18-28.e3
|
artikel
|
| 11 |
Efficacy of Robotic Bronchoscopy for Molecular Marker Analysis in Primary Lung Cancer
|
Yu Lee-Mateus, Alejandra
|
|
|
25 |
1 |
p. e11-e17
|
artikel
|
| 12 |
Genome Wide Association Studies in Small-Cell Lung Cancer. A Systematic Review
|
Enjo-Barreiro, José Ramón
|
|
|
25 |
1 |
p. 9-17
|
artikel
|
| 13 |
Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma
|
Chen, Qin
|
|
|
25 |
1 |
p. 29-38
|
artikel
|
| 14 |
Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery: Brief Report From a Tertiary Referral Centre
|
Orlandi, Riccardo
|
|
|
25 |
1 |
p. e5-e10
|
artikel
|
| 15 |
Lung Cancer in Women: The Past, Present, and Future
|
Florez, Narjust
|
|
|
25 |
1 |
p. 1-8
|
artikel
|
| 16 |
Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum
|
Bochtler, Tilmann
|
|
|
25 |
1 |
p. 72-76
|
artikel
|
| 17 |
Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening
|
Hong, Young-Rock
|
|
|
25 |
1 |
p. 39-49
|
artikel
|
| 18 |
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
|
Friedes, Cole
|
|
|
25 |
1 |
p. 50-60.e6
|
artikel
|
| 19 |
Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy
|
Hashimoto, Kohei
|
|
|
25 |
1 |
p. e26-e34.e6
|
artikel
|
| 20 |
Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis
|
Kashizaki, Fumihiro
|
|
|
25 |
1 |
p. e52-e57.e2
|
artikel
|
| 21 |
Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non–Small-Cell Lung Cancer: A Real-World Study
|
Kobat, Hasan
|
|
|
25 |
1 |
p. e35-e42
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
25 |
1 |
p. A3-A6
|
artikel
|
| 23 |
TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical Resection
|
Soo, Ross Andrew
|
|
|
25 |
1 |
p. 80-84
|
artikel
|
| 24 |
The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report
|
Gao, Ming
|
|
|
25 |
1 |
p. e62-e66
|
artikel
|
Tijdschrift beschrijving